auph stock 3%. The company report on April 15, 2021 that Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. 36 (11. 37 Stock quote and company snapshot for AURINIA PHARMACEUTICALS INC (AUPH), including profile, stock chart, recent news and events, analyst opinions, and research reports. (AUPH Quick Quote AUPH - Free Report) need to pay close attention to the stock based on moves in the options market lately. 38% of gains in the last five trading sessions. AUPH:NMQ price falls below 15-day moving average to 12. Closing Stock Price USD 3. AUPH About About. 78 per share versus a loss of $0. 00 per share. Computershare Trust Company of Canada Shareholder Services Dept. 96 after climbing 6. 56% from its latest closing price compared to the recent 1-year high of $20. Barron's also provides information on historical stock ratings, target prices, company earnings, market Aurinia Pharmaceuticals stock investors activity. Aurinia Stock Has Great Potential, but It’s Not a Buy Right Now. Press Release reported on 04/15/21 that Aurinia Pharmaceuticals to Pr View the real-time AUPH price chart on Robinhood and decide if you want to buy or sell commission-free. DOW 33,981. View Aurinia Pharmaceuticals Inc AUPH investment & stock information. Aurinia Pharmaceuticals currently has 1 hold rating and 7 buy ratings from Wall Street analysts. com member(s) [ on a scale of (Strong Buy) 1. View the latest ratings for AUPH. 63 -0. g AUPH stock opened at $13. Aurinia Daily Chart Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. Get instant access to a free live streaming chart of the Aurinia Pharmaceuticals Inc Stock. News Corp is a global, diversified media and information services company focused on creating and distributing AUPH stock still has to prove its Lupus drug can sell and its price and the competition make that an unclear proposition. (NASDAQ: AUPH / TSX Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stock closed at 13. Get the latest Aurinia Pharmaceuticals Inc (AUPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 03 and a beta of 0. 306 USD for 2026 April 27, Monday with technical analysis. It provides products for patients suffering from serious diseases with a high unmet medical need. IV can AUPH Stock Prediction: AUPH operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmun Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) was trending Tuesday afternoon possibly amid the stock making a new 52-week low. 44 Aurinia (AUPH) Looks Good: Stock Adds 5. Chart, Quote and financial news from the leading provider and award-winning BigCharts. Trade AUPH stock for free with recommended broker TD Ameritrade. Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock discussions in Yahoo Finance's forum. 38M shares. A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin. Aurinia Pharmaceuticals Inc. VICTORIA, British Columbia--(BUSINESS WIRE)--Dec 9, 2019--Aurinia Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc is a biopharmaceutical company. Canada’s main stock index saw an early lift from gains in the base metals sector in early Monday trading. 5%. 30 2017, 3:48 PM ET. Tickers AUPH GSK. 44 1. The company’s stock price has collected 4. Aurinia Pharmaceuticals Inc Stock Price, News and Company Updates. With these potential revenues, we can estimate a maximum potential value for Aurinia, applying a conservative P/S ratio of 4, of about $4. 46%). Get the latest Aurinia Pharmaceuticals Inc AUPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Company is focused on the discovery and development of immunosuppressive therapeutics. Our investment research resources are provided to help you make informed investment decisions. Given the current short-term trend, the stock is expected to fall -25. 93 AUPH IS DOWN -1% SINCE THE BEGINNING OF THE YEAR AUPH IS UP 18% OVER THE PAST 12 MONTHS AUPH IS DOWN -14% OVER THE PAST 1 MONTH The Aurinia Pharm stock analysis makes it easy to digest most publicly released information about Aurinia Pharm and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. 13. Explore commentary on Aurinia Pharmaceuticals Inc. Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH), a mid-cap biotech company, closed trading Monday up by a healthy 26%. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has commenced a registered underwritten public offering of US$150,000,000 of its common shares (the “Offering”). 30 and a high of $20. 79 Million. Dec-21-20 03:40PM : Is AUPH A Good Stock To Buy According To Hedge Funds? Insider Monkey. Get Aurinia Pharmaceuticals, Inc. Find market predictions, AUPH financials and market news. is a stock, traded on the NASDAQ under the AUPH ticker. 73 points to close at $12. 06 and resistance is $12. February 17, 2021 - 6:05 am. Here's Why Everybody's Talking About Aurinia Pharmaceuticals Stock Cory Renauer | Jan 27, 2021 Approval of a new lupus treatment has Aurinia Pharmaceuticals Inc (AUPH) Stock Message Board - InvestorsHub Aurinia is a late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. 00 (Strong Sell) ] in the stock ratings area. AUPH: NASDAQ (Stock) Aurinia Pharmaceuticals Inc Dividend policy None Price as of: APR 12, 11:49 AM EDT $12. (NASDAQ:AUPH) went down by -5. The #1203-4464 MARKHAM STREET VICTORIA BC, BRITISH COLUMBIA, CANADA V8Z 7X8 Aurinia Pharmaceuticals Inc. 's stock price today. 43% out of AUPH. Duration of the delay for other exchanges varies. 62. 00 in company stock. View more earnings on AUPH The analyst consensus estimate would represent a 51. (AUPH) stock. 6% of US stocks. 80, close to its 52-week low of $12. Digging into a few key ratios associated with a stock can provide traders a look of just how risky and/or potentially profitable a an investment option AUPH - Aurinia Pharmaceuticals Inc. 40% Low Float Stock: NO 110. stock news by MarketWatch. AUPH Related ETF s. 2021 is expected to be a huge year for penny stocks. Find fast, actionable information. Find market predictions, AUPH financials and market news. Changing the course of autoimmune disease. How to buy auph stock quote? Buy auph stock quote you can from brokers or on specialized sites. Date Research Firm Action Current Target; 1/27/21: SVB Leerink: Maintains: Get Aurinia Pharmaceuticals Inc (AUPH:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Aurinia shared the data at AUPH | Complete Aurinia Pharmaceuticals Inc. com. According to our AUPH split history records, Aurinia Pharmaceuticals has had 0 splits. Stock Ideas and Recommendations. Aurinia Pharmaceuticals Inc. 39. was the big winner on Wal read article. Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 5% above the current share price. In addition to Jill Diane Leversage, 2 other AUPH executives reported Buy trades in the last month. , AUPH: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events AUPH, $AUPH, Aurinia Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis Aurinia Pharmaceuticals Stock Price History + Charts (AUPH) The following presents a detailed Aurinia Pharmaceuticals stock price history for your review. 8%. 61 at 11:54 BST Apr 23 2021 Key statistics On Tuesday, Aurinia Pharmaceuticals Inc (AUPH:NMQ) closed at 12. Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. Aurinia Pharmaceuticals Inc AUPH Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Sponsor Center Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. AUPH Stock Price From 09/30/2020 To 12/31/2020: Current quotes, charts, news, historical data, and analysis for Aurinia Pharmaceuticals, Inc (AUPH) Stock Free current stock price quotes and data for Aurinia Pharmaceuticals Inc (AUPH). Company Phone Number: 708-4272 Stock Exchange / Ticker: NASDAQ AUPH AUPH is expected to report next financial results on February 23, 2022. 63. Leerink Partners analyst Joseph Schwartz maintained a Buy rating on Aurinia Pharmaceuticals (AUPH – Research Report) on April 8. Schwartz Get the latest price and volume on Aurinia Pharmaceuticals in IBD stock charts. Share your opinion and gain insight from other stock traders and investors. 8 billion only. 50. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Aurinia Pharmaceuticals is having an exceptionally strong day in the trading session today. A slideshow of the Top 10 Hedge Funds Holding AUPH. 50, which is 65. AUPH earnings call for the period ending December 31, 2020. Recently, the weekly return of Aurinia (AUPH) is up 7. Share your opinion and gain insight from other stock traders and investors. Free forex prices, toplists, indices and lots more. Patients treated with LUPKYNIS plus SoC were more than twice as likely to achieve renal response (RR) and experienced a decline in urine protein creatinine ratio (UPCR) twice as fast as patients on typical SoC alone. Glenn Newberry in an earlier post today was asking whether Benlysta from GlaxoSmithKline (GSK), being trialled for lupus nephritis, poses any threat to Aurinia (AUPH). TradingView UK. 00 and a low forecast of $26. 5% in Session. AUPH Stock Price From 09/30/2020 To 12/31/2020: AUPH Stock Predictions. 61% and is outperforming the overall stock market by 14. The all-time high Aurinia Pharmaceuticals Inc stock closing price was 21. 1K. Out of 4 analysts polled in the last 12 months, all 4 are bullish on AUPH stock. | Nasdaq: AUPH | Nasdaq Aurinia Pharmaceuticals Inc. Following George M Milne’s last AUPH Buy transaction on October 22, 2019, the stock climbed by 8. With a price/sales ratio of 33. Unfortunately AUPH wasn’t nearly as popular as these 20 stocks and hedge funds that were betting on AUPH were disappointed as the stock returned -11. 05) per share which beat the analyst consensus estimate of $(0. At this moment we don't have listed any online stock brokers where you can purchase AUPH stock. 26%) Upgrade to Real-Time All stock options outstanding or other equity-based awards at the time of termination, which stock The consensus among analysts is that Aurinia Pharmaceuticals Inc. 14 per share at the end of the most recent trading day (a 1. Potential investors should note that the company is no longer in the AUPH Stock Trend. 46 on January 02, 2020. Symbol %Holdings 3M %Chg; AUPH -15. 65: Market Cap (Millions) USD 110. 67B. Glenn Newberry in an earlier post today was asking whether Benlysta from GlaxoSmithKline (GSK), being trialled for lupus nephritis, poses any threat to Aurinia (AUPH). This recent transaction increases George M Milne’s holding in the company by 100% to a total of $540K. When the transactions were called off in the previous session, Stock hit the highs of $13. Investors in Aurinia Pharmaceuticals Inc. In depth view into AUPH (Aurinia Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. The average price target represents a 139. View detailed financial information, real-time news, videos, quotes and analysis on Aurinia Pharmaceuticals Inc. 67 with a high forecast of $35. NZ business & finance news, stock quotes, currency information and blogs Recent news which mentions NASDAQ:AUPH,NYSE:GSK. 29) per share from the same period last year. At the opening bell, the stock was already trading well into AUPH / Aurinia Pharmaceuticals Inc financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index. 00 Call had some of the Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The firm has a market cap of $1. 09% : Nasdaq Biotechnology Ishares ETF: SBIO View live AURINIA PHARMACEUTICALS INC chart to track its stock's price action. The firm is developing voclosporin, an Aurinia Pharmaceuticals (AUPH) stock price prediction is 25. (NASDAQ: AUPH / TSX: AUP) ("Aurinia" or the "Company") today announced that the U. (AUPH). It is currently valued at $12. 76 percent increase over losses of $(0. 19M and currently shorts hold a 4. m. com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles. Message Board Total Posts: 50 Changing the course of autoimmune disease. 53 and a beta of 0. AUPH Announces The Pricing Of A Public Offering. Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0. Company’s stock value dipped to $12. S&P 500 4,187. AUPH has closed above bottom band by 42. 60. In this period, the stock has traded at a high of -12. Zacks. 33% Watchlist Overview. 8 billion. Benlysta is a monoclonal antibody that binds to and inhibits BAFF (B-cell activating factor). AUPH stock was acquired by a variety of institutional investors in the last quarter, including DnB Asset Management AS, Rothschild Investment Corp IL, Coastal Investment Advisors Inc. 27: Latest Filing Dates: Annual December 31, 2014: Semi Annual N/A: Quarterly June 30, 2015 Download Historical Stock Quotes for Aurinia Pharm Ord [NASDAQ,AUPH] in a range of formats. The beta is 0. Dec-17-20 11 View AUPH's options chain, put prices and call prices at MarketBeat. the stock is 42. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that it will release its first quarter 2021 financial results on Thursday, May 6, 2021, after the markets close. 20, after setting-off with the price of $13. AUPH: Stock Option (right to buy) M - Exercise: D: 6. AUPH is rated 2. Specifically, they have bought $33,762. On PennyStocks. Why Aurinia Pharmaceuticals Stock Is Flying Today. 7% narrower than normal. Research news, charts, stock market performance and earnings. 26 1. 00 - 5. 18 (1. AUPH Stock Message Board for Investors. 353: Total Shares Outstanding (Millions) 32. Stock Price Statistics. 50 in the current 52-week trading range. 57%. April 28, 2021 • 6:30am EDT. 5% since the end of the third quarter Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. AUPH updated stock price target summary. ET; CNBC is the world leader in business news and real-time financial market coverage. 5% in Session. 3K. Latest AURINIA PHARMACEUTICALS (AUPH) stock news, Aurinia Pharmaceuticals, Inc. We are committed to transforming people’s lives by delivering therapeutics that change the course of autoimmune disease. (AUPH) is a Buy stock at the moment, with a recommendation rating of 1. -- Aurinia Pharmaceuticals (NASDAQ: AUPH) reported a fourth-quarter 2019 loss of $0. Sign Up Aurinia Pharmaceuticals (AUPH) stock price, charts, trades & the US's most popular discussion forums. However, this figure declines on the past 10-day timeline to an average of 3. Aurinia Pharmaceuticals Inc - Common Shares (ticker: AUPH) Stock Menu For: AUPH Price Summary Gurus' Score On AUPH Institutions' Score On AUPH Gurus' Holdings On AUPH Institutions' Holdings On AUPH Insiders' Score On AUPH Stock's News On AUPH SEC Filings On AUPH AUPH Stock Insider Trades - Buys and Sells - Aurinia Pharmaceuticals Inc : a breakdown of the latest and past insider buys and sells in the stock. AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. Its focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis. has a 52-week low of $9. Aurinia Pharmaceuticals (AUPH) has 0 splits in our AUPH split history database. 01 on Thursday. (NASDAQ:AUPH) stock in terms of its daily trading volume indicates that the 3-month average is 4. The firm’s 50 day moving average price is $14. Aurinia Pharmaceuticals Inc Stock Price, News and Company Updates. 89 Million. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area Among the technology companies in the top ten are Apple with an increase of 4,419 percent and Netflix with 2840 percent. 99% The firm shows a Beta (market volatility) of 0. 8% AWAY FROM ALL-TIME HIGHS OF $21. AUPH stock still has to prove its Lupus drug can sell and its price and the competition make that an unclear proposition. 01. 81% above its 52-week low of 11. 7. 1 out of 9 have rated it as a Hold, with 7 advising it as a Buy. Today, the average trading volume of AUPH was 1. AUPH need to pay close attention to the stock based on moves in the options market lately. Stocks. AUPH Stock Price (NASDAQ), Score, Forecast, Predictions, and Aurinia Pharmaceuticals Inc News. auph is currently trading in the 20-30% percentile range relative to its historical Stock Score levels. That is because the Feb 19, 2021 $15. operates as a clinical stage biopharmaceutical company, which engages Options chains for selling calls and puts, for symbol AUPH, from Stock Options Channel February 9, 2021 - The year-to-date (YTD) return or performance of Aurinia (AUPH) is up 20. AUPH Aurinia Pharmaceuticals News . 98% during the next 3 months and, with a 90% probability hold a price between $8. Aurinia Pharmaceuticals Inc. 41% Highly Volatile Aurinia Pharmaceuticals Inc. QQQ 341. 50. 00 on average by 2 ValueForum. 08 and a 200-day moving average of $14. 66% increase from the last price of $12. Aurinia Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has presented additional efficacy data from the AURA-LV and AURORA 1 trials of Lupkynis (voclosporin) in lupus nephritis (LN). AUPH, DBI, FRAN and NLTX among Aurinia Pharmaceuticals (AUPH) is a late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need. The volatility of a stock over a given time period. AUPH stocks went down by -11. In the release, the company said it will be offering 11,115,165 shares of common stock at a price of $15. None of the analysts rate the stock as a Sell, while 1 rate it as Overweight. Find market predictions, AUPH financials and market news. (AUPH). 25, marking a nearly 92% upside potential from where the stock is Aurinia Pharmaceuticals Inc. 27 on Tuesday. The 12-month average price target stands at $13. 72% increase in the company's EPS figure. 33%. 17 -1. 44%: Industry Group Biotechnology: 52 wk. Get the latest stock price for Aurinia Pharmaceuticals Inc (AUPH:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. Aurinia Pharmaceuticals Inc. com. Dive deeper with interactive charts and top stories of Aurinia Pharmaceuticals Inc. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aurinia Pharmaceuticals against related stocks people have also bought. Trades still trying to find my way of finding stock for back ground to see if it is a good buy Gave lots of good info about the stocks that were TSX:AUP Past and Future Earnings April 5th 2020. Aurinia Pharmaceuticals to Release First Quarter 2021 Financial Results on May 6, 2021 Read Press Release View All News Aurinia (AUPH) Looks Good: Stock Adds 5. 1% and a 47. Find market predictions, AUPH financials and market news. Insiders buying/selling: Aurinia Pharmaceuticals (NASDAQ:AUPH) In the past three months, Aurinia Pharmaceuticals insiders have bought more of their company’s stock than they have sold. AUPH — Current Quote: Quotes delayed 20 minutes. Today, the Non-Executive of Aurinia Pharmaceuticals (AUPH – Research Report), Jill Diane Leversage, bought shares of AUPH for $42. 51 and $9. 17 0. Just click the link above. and hear what the Aurinia Pharmaceuticals Inc. com) is the top online destination for all things Micro-Cap Stocks. 56% or -0. Aurinia Pharmaceuticals Inc. AUPH — Key Stats (updated Friday, April 16, 10:23 AM) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Aurinia Pharmaceuticals is having an incredibly strong start to the trading session today. 30K shares and market capitalization of 1. (AUPH) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Food and Drug Administration recently made voclosporin (brand name Aurinia Pharmaceuticals Stock Forecast, AUPH stock price prediction. 83 and a 52-week high of $20. Email Alerts. Aurinia Pharmaceuticals Inc. NASDAQ Updated Apr 29, 2021 4:06 PM AUPH 12. Message Board Total Posts: 50 Transfer Agent. 62% Heavily Owned by Institutions: NO 17. com: 10:52 AM: Aurinia is up 25% on voclosporin win; expects net revenue at $65K per patient - SeekingAlpha: 8:26 AM: BB, GME, AMC and AUPH among premarket gainers Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. 93: auph is down -9% since the beginning of the year: auph is down -21% over the past 12 months: auph is down -9% over the past 1 month: n/a% of all auph investors are betting against auph: num investors short auph has gone up 37% versus last month From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term. (AUPH) is headed up in the market today. 47%. The stock has a consensus analyst rating of "Buy. 27/04/2021 07:08:09 1-888-992-3836 Free AUPH support price is $12. Chart, Quote and financial news from the leading provider and award-winning BigCharts. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how AUPH will perform in the near Aurinia Pharmaceuticals Inc real-time stock news and price updates. Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) recently jumped thanks to excitement about the company's new lupus treatment. AUPH, Aurinia Pharmaceuticals - Stock Investment Research, IBD Stock Charts - Investors. The company has a market cap of $1. (AUPH) chart. AUPH's fiscal year ends in December Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. 72 (based on 1 day standard deviation move). Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat Aurinia Pharmaceuticals Inc. AURINIA PHARMACEUTICALS INC. AUPH Stock Quotes API . AUPH Stock Message Board for Investors. Get Aurinia Pharmaceuticals, Inc. View the latest AUPH stock quote and chart on MSN Money. 1d 5d 1m 3m 1y 5y YTD. 5% away from all-time highs of $21. 42: As of Date September 18, 2015: One Year Performance 0. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aurinia Pharmaceuticals against related stocks people have also bought. The best long-term & short-term Aurinia Pharmaceuticals share price prognosis for 2021, 2022 Aurinia (NASDAQ: AUPH) stock is a bet on a clinical-stage biotech firm tackling lupus nephritis with its drug, Lupkynis. Detailed list of analyst forecasts Check if AUPH has a Buy or Sell Evaluation. The energy, financial, technology, and health care sectors all clocked in with initial gains, while industrial, telecom, and utilities were all lower. The company’s stock price has collected 4. Aurinia Pharmaceuticals, Inc. Food and AUPH Description — Aurinia Pharmaceuticals Inc Aurinia Pharmaceuticals is a biopharmaceutical company engaged in the business of development and commercialization of therapeutic drugs. The stock has gained considerable momentum in recent days and especially so after it announced its Q4 2020 financial results along with the same for the full year 2020. There seems to be massive anticipati AUPH stock quote, chart and news. It provides products for patients suffering from serious diseases with a high unmet medical need. Free current stock price quotes and data for Aurinia Pharmaceuticals Inc (AUPH). () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share AURINIA PHARMACEUTICALS INC. The Aurinia Pharmaceuticals stock forecast is 25. 79 billion, a PE ratio of -9. 60, set on Apr 20, 2021. 39,021 A high-level overview of Aurinia Pharmaceuticals Inc. Dec-21-20 03:40PM : Is AUPH A Good Stock To Buy According To Hedge Funds? Insider Monkey. Old updates for posterity: And this one is not AS binary as many think: 31 October: Aurinia Announces Initiation of Patient Dosing in Phase 2/3 AUDREY™ Clinical Trial for Dry Eye Syndrome - Voclosporin ophthalmic solution (VOS) AUDREY trial results anticipated in the second half of 2020 – [quote]VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. 59. (NASDAQ:AUPH, TSX:AUP) (Aurinia or the Company) today announced a favorable assessment regarding the cost-effectiveness and value of LUPKYNIS™ (voclosporin), based on an independent analysis issued by the Institute for Clinical and Economic Review (ICER) in a revised Evidence Report issued on March 12, 2021. . 68% in the last 52 weeks. 5%. Is a component of indices and it is traded on NASDAQ exchange. Stock Price » 12. 79: Last as of 4 Aurinia Pharmaceuticals Inc. 39, 6. Press Release reported on 04/15/21 that Aurinia Pharmaceuticals to Pr Market / Outlet Security Exchange Symbol Type; Aurinia Pharmaceuticals / Aurinia Pharmaceuticals Inc Ordinary Shares: CA XNAS: AUPH: EQ0038193100001001 Tradable: January 22, 2021 - 8:24 pm. 21% of the stock of Aurinia Pharmaceuticals is held by institutions. As … Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. AUPH currently public float of 111. Research news, charts, stock market performance and earnings. 34, so AUPH's price volatility has been lower than the market average. We are committed to transforming people’s lives by delivering therapeutics that change the course of autoimmune disease. View live AURINIA PHARMACEUTICALS INC chart to track its stock's price action. 77 and its 200-day moving average price is $14. 00 and the lowest AUPH stock price forecast at $28. View the investor activity. Aurinia Pharm Ord (AUPH) Implied Volatility - Implied Volatility (IV) is the estimated volatility of the underlying stock over the period of the option. Dow Jones, a News Corp company About WSJ. 9394, which signifies possible diversification benefits within a given portfolio. 07% : Aurinia Pharm Ord: IBB : 0. | 14,544 followers on LinkedIn. 's stock price today. 100 University Avenue 9th Floor Toronto, ON M5J 2Y1 Canada T: +1-514-982-7555 For the readers interested in the stock health of Aurinia Pharmaceuticals Inc. The latest closing stock price for Aurinia Pharmaceuticals Inc as of April 27, 2021 is 12. Stock quote and company snapshot for AURINIA PHARMACEUTICALS INC (AUPH), including profile, stock chart, recent news and events, analyst opinions, and research reports. New! 12Stocks. The stock seems to be languishing because there are just no news events and there will not be any until Phase 3 results come out. AUPH — Current Quote: Quotes delayed 20 minutes. Should I buy or sell AUPH stock? If you are thinking about buying AUPH, make sure you check out the free AUPH stock predictions report provided by MarketClub. 00, with the highest AUPH stock price forecast at $35. The latest rating update was made on Jun. 56% from its latest closing price compared to the recent 1-year high of $20. 36, Aurinia Pharmaceuticals Inc has a higher such ratio than 92. . Zacks. Food and Drug Administration (FDA) has approved LUPKYNIS TM (voclosporin) in combination with a background immunosuppressive therapy regimen to treat adult patients with active lupus nephritis (LN). " A "buy" rating indicates that analysts believe AUPH will outperform the market and that investors should add to their positions of Aurinia Pharmaceuticals. 06 -30,000 0 2021-02-02: 2021-01-29: 4: Hayden Michael R: AUPH: Stock Option (right to buy) M - Exercise: D: 5. (AUPH). Right now AUPH is only $13 a share, and with the high probability of being approved in a couple weeks, I have a feeling this thing will 🚀 straight to the moon, and evidence of that is how it jumped to $21 last December when it released its phase 3 trial results. Investors in Aurinia Pharmaceuticals Inc. 14) by 64. com introduces Big Monthly, Weekly & Daily Charts I am long AUPH. 00 in company stock and sold $0. 15. Based on 4 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. Stock Price » 12. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued. April 07, 2021. Aurinia Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc AUPH Stock Message Board: High plains drifter. You can unlock it all now. Aurinia Pharmaceuticals Inc. View live AURINIA PHARMACEUTICALS INC chart to track its stock's price action. 5% in Session. 30 and a one year high of $20. 50. Healthcare Investor Conference. AUPH stock quote, chart and news. Follow AUPH. The average price target is $29. The stock, focused on the biotechnology space, is presently priced at $4. The Aurinia Pharmaceuticals Inc 52-week high stock price is 20. Sign up for email alerts for Press Releases & SEC Filings. 50. 38. (NASDAQ:AUPH) went down by -5. Bollinger Bands are 26. 69 billion, a PE ratio of -9. The firm is developing voclosporin, an AUPH stock quote, chart and news. Aurinia Pharmaceuticals Inc. Range USD 1. 00. Aurinia Pharmaceuticals Inc. The stock has a 50-day moving average of $15. When the opening bell rang, the stock was already trading well Penny Stocks (PennyStocks. To help provide a sense of the short to long-term trend, included is an interactive Aurinia Pharmaceuticals stock chart which you can easily adjust to the time frame of your choosing (e. 21% so far in today’s session. 01% lower on its value in year-to-date trading and has touched a low of $11. 3% success rate. 59% and a quarterly performance of -4. Compare. (NASDAQ: AUPH) is -7. According to . According to TipRanks. This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AUPH stock will trade within this expected range on the day. AUPH Stock investors sentiment based on 391,885 active investor portfolios. 39 with a heavy trading volume of 6428803 shares. 14 per share expected. 51. . View today's stock price, news and analysis for Aurinia Pharmaceuticals Inc. 39: Last as of 4 Today, the Chairman of Aurinia Pharmaceuticals (AUPH – Research Report), George M Milne, bought shares of AUPH for $262. An analysis of the Aurinia Pharmaceuticals Inc. Get Aurinia Pharmaceuticals, Inc. 81 following its announcement of positive data from its pivotal AURORA Phase 3 trial of voclosporin, in combination with mycophenolate and low-dose corticosteroids, in the treatment of lupus nephritis. auph stock quote are also included in the list of such companies. 23 % change compared to the prior day closing price) with a volume of 961. 641677 USD. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that it will release its fourth quarter and year end 2020 financial results on Wednesday, February 24, 2021, after the markets close. The post Aurinia Stock Has Great Potential, but It's Not a Buy Right Now appeare 4 days ago - InvestorPlace Aurinia Pharmaceuticals Inc is a biopharmaceutical company. 87. That is because the Feb 19 AUPH has a current market cap of 1. The stock price has decreased by -15. One stock I'm adding to this morning is an old favorite, Aurinia Pharmaceuticals This drug is widely believed to be inferior to AUPH's Voclosporin and the news has been anticipated. Home Homepage Membership Levels General Discussion Complete Stock List Value Investing Forum Value Conference The book Podcast Membership Data Coverage Founder's Message Free Trial Full Year – Finally, over the last year, we’ve seen movement of 12. AUPH’s Market Performance. 41 - 5. Zacks. 13% -6. It provides products for patients suffering from serious diseases with a high unmet medical need. , Private Capital Group LLC, Valeo Financial Advisors LLC, and Pacifica Partners Inc. In depth view into AUPH (Aurinia Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Dec-17-20 11 Aurinia Pharmaceuticals Inc AUPH Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Sponsor Center Aurinia Pharmaceuticals is a biopharma stock you should own, Mackie says October 31, 2019 All eyes are on Aurinia Pharmaceuticals (Aurinia Pharmaceuticals Stock Quote, Chart, News NASDAQ:AUP Current stock quote for Aurinia Pharmaceuticals Inc ( AUPH ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion TradingView India. View real-time stock prices and stock quotes for a full financial overview. 25M Heavily Owned by Insiders: NO 0. is a biopharmaceutical company. com, Schwartz is a 5-star analyst with an average return of 16. 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32. AUPH Quick Overview Profitable Last Quarter: N/A Cash Flow Positive Last Quarter: N/A PE Under 25: N/A Trading At or Less than Sales: N/A Trading At or Less than Book Value: N/A Potential Short Squeeze Opportunity: NO 5. S. 29 percent. 00. Why Aurinia Pharmaceuticals Stock Is Flying Today - Motley Fool: 2:48 PM "The Buzz" Show: Aurinia Pharmaceuticals (NASDAQ: AUPH) Receives FDA Approval for LUPKYNIS - FinancialBuzz. (NASDAQ:AUPH). Below are the technical levels to watch on the chart. This is a 82. View today's stock price, news and analysis for Aurinia Pharmaceuticals Inc. 83 0. Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aurinia Pharmaceuticals Inc. 47% and is outperforming the overall market by 6. (Roche and Pfizer sit at P/s of about 4). Customise your news feed and gain expert insights into AUPH on the Nasdaq with Financial Juice for free today! AUPH - Aurinia Pharmaceuticals Inc. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). 57. THE STOCK IS 37. Message board - Online Community of active, educated investors researching and discussing Aurinia Pharmaceuticals Inc. View the latest Aurinia Pharmaceuticals Inc. AUPH Stock Summary The ratio of debt to operating expenses for Aurinia Pharmaceuticals Inc is higher than it is for about only 8. Long on AUPH with entry around 15, just crossed over the 50ma on the 15m. Following Jill Diane Leversage’s last AUPH Buy transaction on June 05, 2020, the stock climbed by 1. Stocktwits is the largest social network for finance. 36. Analyst Rating View All Ratings. 66 at the end of this 3-month period. 38% of gains in the last five trading sessions. The company’s shares closed last Friday at $12. Aurinia Pharmaceuticals Inc. Dec-21-20 03:40PM : Is AUPH A Good Stock To Buy According To Hedge Funds? Insider Monkey. Currently its trading at $ 12. Looking for insights on Aurinia-pharmaceuticals (NSD:AUPH) stock? View AUPH's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. View live AURINIA PHARMACEUTICALS INC chart to track its stock's price action. has a one year low of $11. 641677 USD for 2022 April 27, Wednesday; and 104. 87. Benlysta is a monoclonal antibody that binds to and inhibits BAFF (B-cell activating factor). Can anyone make a bear case for AUPH? It’s always good to think about what could go wrong. com Aurinia Pharmaceuticals Inc Stock Institutional Ownership and Insider Ownership - : the historical trend of stock ownership among institutions and insiders. I analyze these and argue that the second, a new licensing agreement, is not negative, rather it's a positive for stockholders. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has presented additional efficacy data from the AURA-LV and AURORA 1 trials of Lupkynis (voclosporin) in lupus nephritis (LN). 27%, while its annual performance rate touched -34. 39. The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. , AUPH: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events Aurinia Pharmaceuticals Inc Stock Price Forecast, "AUPH" Predictons for2021 Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock discussion in Yahoo Finance's forum. Ratios That Are Notable. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. 55% of stocks in our set. Barron's also provides information on historical stock ratings, target prices, company earnings, market View the real-time AUPH price chart on Robinhood and decide if you want to buy or sell commission-free. . Payout AUPH stock might explode this week because its leading drug to treat LN just got FDA approval after market close Friday. [NASDAQ: AUPH] loss -5. Follow along and learn as I perform a quick stock chart technical analysis review on the Aurinia Pharmaceuticals Inc. A slideshow of the Top 10 Hedge Funds Holding AUPH. Dec-17-20 11 We have 9 different ratings for every stock to help you appreciate its future potential. The stock raced higher in response to the FDA's approval of the company's oral lupus nephritis drug, Lupkynis (aka voclosporin). 36% and a low of 37. . Aurinia Presents Integrated Time To Renal Response Data From The AURA-LV And AURORA Trials, Along With Voclosporin Drug-Drug Interaction Data At ACR Convergence 2020 Aurinia Pharmaceuticals Inc is a biopharmaceutical company. 59%: One Month Performance -1. Given this is a high-level overview, I won’t go into details of AUP’s upcoming projects, however, bear in mind that typically a biotech has lumpy cash flows which are contingent on the product type and stage of development the company is in. Looking at the AUPH split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. 95% ratio of that float. Aurinia Pharmaceuticals issued a press release late yesterday, announcing the pricing of a public offering of common stock. AUPH opened at $14. All eyes are on Aurinia Pharmaceuticals (Aurinia Pharmaceuticals Stock Quote, Chart, News NASDAQ:AUPH), which just announced the start of a patient dosing in its Phase 2/3 clinical trial for its AUPH -- USA Stock USD 12. (NASDAQ: AUPH) shares have surged after hours, currently trading up 124% to $18. Very rarely can a stock in biotech be considered a “sure thing”, but AUPH seems to be it. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the executive management team will participate in multiple upcoming investor conferences including the: Cowen 41st Annual virtual Healthcare Conference fireside chat on Thursday, March 4, 2021 at 2:10 p. 's stock price today. S. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. (Nasdaq: AUPH), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today announced that the U. Investors who might be looking to invest in pharmaceutical stocks could have a look at the Aurinia Pharmaceuticals (NASDAQ: AUPH) stock. None have rated the stock as Underweight. Get the hottest stocks to trade every day before the market opens 100% free. 40% for the week, with a monthly drop of -3. Get the latest Aurinia Pharmaceuticals Inc (AUPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Aurinia shared the data at Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. 7 “Perfect 10” Healthcare Stocks to Buy Now After Patent News, Aurinia Aurinia (AUPH) Looks Good: Stock Adds 5. Get the hottest stock AUPH, Aurinia Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines AUPH stock has fallen on two recent developments. Telsa Inc. auph stock